搜尋
10X Genomics Inc
TXG添加自選
70.110USD
+1.520+2.22%
收盤 09-14 16:00（美東）
9.14B總市值
虧損本益比TTM
關於 10X Genomics Inc 公司
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
10X Genomics Inc 簡介
公司代碼TXG
公司名稱10X Genomics Inc
上市日期Sep 12, 2019
CEOSaxonov (Serge Wilson)
員工數量1306
證券類型Ordinary Share
年結日Sep 12
公司地址6230 Stoneridge Mall Road
城市PLEASANTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94588
電話19254017300
網址https://www.10xgenomics.com/
公司代碼TXG
上市日期Sep 12, 2019
CEOSaxonov (Serge Wilson)
10X Genomics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.07M
-0.01%
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.07M
-0.01%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
358.44K
-5.58%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
358.44K
-5.58%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+22.53%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
91.41K
-15.12%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
91.41K
-15.12%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
68.28K
+12.93%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
68.28K
+12.93%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
37.45K
+23.58%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.07M
-0.01%
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.07M
-0.01%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
358.44K
-5.58%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
358.44K
-5.58%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+22.53%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
91.41K
-15.12%
常見問題
10X Genomics Inc的前五大股東是誰？
10X Genomics Inc的前五大股東如下：Mr. Serge Wilson Saxonov, Ph.D.
有多少機構持有10X Genomics Inc(TXG)的股份？
截至2026Q1，共有726家機構持有10X Genomics Inc的股份，合計持有的股份價值約為140.84M，占公司總股份的118.45% 。與2025Q4相比，機構持股有所增加，增幅為-2946322.00。
哪個業務部門對10X Genomics Inc的收入貢獻最大？
在2026Q1，Consumables業務部門對10X Genomics Inc的收入貢獻最大，創收130.75M，占總收入的86.57% 。